# Drospirenone + Ethinylestradiol

## YAZ 悅姿錠 (28 tablets/box)

| TAH Drug Code      | [OYAZ](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OYAZ)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treatment of moderate acne vulgaris in women at least 14 years of age, who have no known contraindications to OC therapy, & have achieved menarche                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Start on day 1 of menstrual cycle, take one light pink tablet QD for 24 consecutive days followed by one white inert tablet QD for 4 days. If YAZ is first taken later than the first day of the menstrual cycle, other contraceptive methods must be used until after the first 7 consecutive days of product administration.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Yaz is contraindicated in women known to have or have had the following conditions: 1. Impaired kidney function. 2. Adrenal insufficiency. 3. Women at high risk for arterial or venous thrombotic diseases, such as: - Women aged 35 and above who smoke. - Current or past history of deep vein thrombosis or pulmonary embolism. - History of cerebrovascular disease. - Coronary artery disease. - Thrombotic valvular or rhythm diseases of the heart (e.g., valvular disease or atrial fibrillation associated with subacute bacterial endocarditis). - Congenital or acquired hypercoagulopathies. - Uncontrolled hypertension. - Diabetes with vascular complications. - Headache with focal neurological symptoms, or women aged 35 and above with migraine headaches with or without aura. 4. Undiagnosed abnormal uterine bleeding. 5. Past or present breast cancer or other estrogen- or progestin-sensitive cancer. 6. Liver tumors (benign or malignant) or liver disease. 7. Pregnancy, as there is no reason to use combined oral contraceptives during pregnancy. 8. Concomitant use with hepatitis C medications containing ombitasvir, paritaprevir/ritonavir with or without dasabuvir, which may lead to elevated ALT levels. |
| Adverse Effects    | Upper respiratory infection, headache, breast pain, vag moniliasis, leukorrhea, diarrhea, nausea, vomiting, vaginitis, abdominal pain, flu syndrome, dysmenorrhea, moniliasis, allergic reaction, UTI, accidental injury, cystitis, tooth disorder, sore throat, infection, fever, surgery, sinusitis, back pain, emotional lability, migraine, suspicious Papanicolaou smear, dyspepsia, rhinitis, acne, gastroenteritis, bronchitis, pharyngitis, skin disorder, intermenstrual bleeding, decreased libido, weight gain, pain, depression, increased cough, dizziness, menstrual disorder, pain in extremity, pelvic pain & asthenia                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Pregnancy          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | Contraindicated                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/drospirenone-and-ethinylestradiol-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

